The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Open accessAbstract
The integration of mass spectrometry-based proteomics with next-generation DNA and RNA sequencing profiles tumors more comprehensively. Here this "proteogenomics" approach was applied to 122 treatment-naive primary breast cancers accrued to preserve post-translational modifications, including protein phosphorylation and acetylation. Proteogenomics challenged standard breast cancer diagnoses, provided detailed analysis of the ERBB2 amplicon, defined tumor subsets that could benefit from immune checkpoint therapy, and allowed more accurate assessment of Rb status for prediction of CDK4/6 inhibitor responsiveness. Phosphoproteomics profiles uncovered novel associations between tumor suppressor loss and targetable kinases. Acetylproteome analysis highlighted acetylation on key nuclear proteins involved in the DNA damage response and revealed cross-talk between cytoplasmic and mitochondrial acetylation and metabolism. Our results underscore the potential of proteogenomics for clinical investigation of breast cancer through more accurate annotation of targetable pathways and biological features of this remarkably heterogeneous malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationGene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Learning the parts of objects by non-negative matrix factorization
Lee, D. D., & Seung, H. S. (1999) · Nature · doi:10.1038/44565 · Cited by 13,868
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Self-citationRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Self-citationAdvances in Neural Information Processing Systems 14: Proceedings of the 2001 Conference
(2002) · The MIT Press eBooks · doi:10.7551/mitpress/1120.001.0001 · Cited by 8,890
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“Proteogenomic Metabolic Profiling and Acetylproteomics Highlight Subtype-Specific Metabolism Therapeutic targeting of abnormal cancer metabolism is garnering increased attention (Pavlova and Thompson, 2016; Phan et al., 2014).”
BackgroundThe Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationThe Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Self-citationLamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationSensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Self-citationMaftools: efficient and comprehensive analysis of somatic variants in cancer
Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C., & Koeffler, H. P. (2018) · Genome Research · doi:10.1101/gr.239244.118 · Cited by 4,935
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
ALGORITHMS FOR NON-NEGATIVE MATRIX FACTORIZATION
Seung, D., & Lee, L.-W. (2001) · Cited by 4,753
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Self-citationxCell: digitally portraying the tissue cellular heterogeneity landscape
Aran, D., Hu, Z., & Butte, A. J. (2017) · Genome Biology · doi:10.1186/s13059-017-1349-1 · Cited by 4,397
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,183
Self-citationYang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,685
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,550
Self-citationA Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
Self-citationNext-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Self-citationWebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144
Self-citationDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 1×
“MutSig2CV (Lawrence et al., 2014) was run on these filtered results to evaluate the significance of mutated genes and estimate mutation densities of samples.”
MethodSelf-citationATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Self-citationThe Reactome Pathway Knowledgebase
Fabregat, A., Jupe, S., Matthews, L., Sidiropoulos, K., Gillespie, M., Garapati, P., Haw, R., Jassal, B., Korninger, F., May, B., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1132 · Cited by 2,855
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1090 · Cited by 2,312
Self-citationUnderstanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., et al. (2016) · Nature · doi:10.1038/nature17676 · Cited by 2,218
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180
Self-citationA Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Self-citationAbsolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationScaling accurate genetic variant discovery to tens of thousands of samples
Poplin, R., Ruano-Rubio, V., DePristo, M. A., Fennell, T. J., Carneiro, M. O., Van der Auwera, G. A., Kling, D. E., Gauthier, L. D., Levy-Moonshine, A., Roazen, D., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/201178 · Cited by 1,915
Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, F., Baselga, J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,827
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Self-citationStrelka2: fast and accurate calling of germline and somatic variants
Kim, S., Scheffler, K., Halpern, A. L., Bekritsky, M. A., Noh, E., Källberg, M., Chen, X., Kim, Y., Beyter, D., Krusche, P., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0051-x · Cited by 1,632
Self-citationA flexible R package for nonnegative matrix factorization
Gaujoux, R., & Seoighe, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-367 · Cited by 1,547
Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
Self-citationLehmann, B. D., Jovanović, B., Chen, X., Estrada, M. V., Johnson, K. N., Shyr, Y., Moses, H. L., Sanders, M. E., & Pietenpol, J. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157368 · Cited by 1,426
Self-citationg:Profiler—a web server for functional interpretation of gene lists (2016 update)
Reimand, J., Arak, T., Adler, P., Kolberg, L., Reisberg, S., Peterson, H., & Vilo, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw199 · Cited by 1,229
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S., & Swanton, C. (2016) · Genome Biology · doi:10.1186/s13059-016-0893-4 · Cited by 1,216
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · cited 1×
“Broad dependence of tissues on glucose and products of respiration suggests that the therapeutic window for targeting increased aerobic glycolysis or compromised TCA cycle enzymes is narrow (Luengo et al., 2017).”
BackgroundQuantitative Proteomics of the Cancer Cell Line Encyclopedia
Nusinow, D. P., Szpyt, J., Ghandi, M., Rose, C. M., McDonald, E. R., Kalocsay, M., Jané-Valbuena, J., Gelfand, E., Schweppe, D. K., Jedrychowski, M., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.023 · Cited by 957
Self-citationThe single-cell pathology landscape of breast cancer
Jackson, H. W., Fischer, J. R., Zanotelli, V. R. T., Ali, H. R., Mechera, R., Soysal, S. D., Moch, H., Muenst, S., Varga, Z., Weber, W. P., et al. (2020) · Nature · doi:10.1038/s41586-019-1876-x · Cited by 900
Triple-negative breast cancer in African-American women: disparities versus biology
Dietze, E. C., Sistrunk, C., Miranda-Carboni, G., O'Regan, R., & Seewaldt, V. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3896 · Cited by 898
DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
Cotto, K. C., Wagner, A. H., Feng, Y.-Y., Kiwala, S., Coffman, A. C., Spies, G., Wollam, A., Spies, N. C., Griffith, O. L., & Griffith, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1143 · Cited by 885
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Verdin, E., & Ott, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3931 · Cited by 877
Kim, H., & Park, H. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm134 · Cited by 863
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Self-citationProteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.030 · Cited by 799
Self-citationThe Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.004 · Cited by 700
Self-citationCOMPARTMENTS: unification and visualization of protein subcellular localization evidence
Binder, J. X., Pletscher-Frankild, S., Tsafou, K., Stolte, C., O'Donoghue, S. I., Schneider, R., & Jensen, L. J. (2014) · Database · doi:10.1093/database/bau012 · Cited by 668
Mounir, M., Lucchetta, M., Silva, T. C., Olsen, C., Bontempi, G., Chen, X., Noushmehr, H., Colaprico, A., & Papaleo, E. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006701 · Cited by 530
Self-citationAngelova, M., Charoentong, P., Hackl, H., Fischer, M. L., Snajder, R., Krogsdam, A. M., Waldner, M. J., Bindea, G., Mlecnik, B., Galon, J., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0620-6 · Cited by 522
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Weinert, B. T., Narita, T., Satpathy, S., Srinivasan, B., Hansen, B. K., Schölz, C., Hamilton, W. B., Zucconi, B. E., Wang, W. W., Liu, W. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.033 · Cited by 509
Self-citationImplementing Genome-Driven Oncology
Hyman, D. M., Taylor, B. S., & Baselga, J. (2017) · Cell · doi:10.1016/j.cell.2016.12.015 · Cited by 503
Oncotator: Cancer Variant Annotation Tool
Ramos, A. H., Lichtenstein, L., Gupta, M., Lawrence, M. S., Pugh, T. J., Saksena, G., Meyerson, M., & Getz, G. (2015) · Human Mutation · doi:10.1002/humu.22771 · Cited by 501
Self-citationCDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
Goel, S., DeCristo, M. J., McAllister, S. S., & Zhao, J. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.002 · Cited by 501
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
Gillette, M. A., & Carr, S. A. (2013) · Nature Methods · doi:10.1038/nmeth.2309 · Cited by 495
Self-citationPhan, L. M., Yeung, S. J., & Lee, M. H. (2014) · PubMed · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 490
Proteogenomic Characterization of Endometrial Carcinoma
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485
Self-citationMertins, P., Tang, L. C., Krug, K., Clark, D. J., Gritsenko, M. A., Chen, L., Clauser, K. R., Clauss, T. R., Shah, P., Gillette, M. A., et al. (2018) · Nature Protocols · doi:10.1038/s41596-018-0006-9 · Cited by 479
Self-citationParkes, E. E., Walker, S. M., Taggart, L. E., McCabe, N., Knight, L. A., Wilkinson, R., McCloskey, K. D., Buckley, N. E., Savage, K. I., Salto-Tellez, M., et al. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw199 · Cited by 462
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
Lee, J.-O., Russo, A. A., & Pavletich, N. P. (1998) · Nature · doi:10.1038/36038 · Cited by 459
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Kim, J., Mouw, K. W., Polak, P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Van Allen, E. M., D'Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 413
Self-citationHypermutation in human cancer genomes: footprints and mechanisms
Roberts, S. A., & Gordenin, D. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3816 · Cited by 405
Mertins, P., Yang, F., Liu, T., Mani, D. R., Petyuk, V. A., Gillette, M. A., Clauser, K. R., Qiao, J. W., Gritsenko, M. A., Moore, R. J., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036392 · Cited by 400
Self-citationEllis, M. J., Suman, V. J., Hoog, J., Goncalves, R., Sanati, S., Creighton, C. J., DeSchryver, K., Crouch, E., Brink, A., Watson, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4406 · Cited by 366
Self-citationLysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Regulatory Mechanisms in the Control of Protein Kinase
Flockhart, D. A., & Corbin, J. D. (1982) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238209108705 · Cited by 353
Lehmann, B. D., Bauer, J. A., Schafer, J. M., Pendleton, C. S., Tang, L., Johnson, K. C., Chen, X., Balko, J. M., Gómez, H., Arteaga, C. L., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0406-x · Cited by 342
Self-citationA Curated Resource for Phosphosite-specific Signature Analysis
Krug, K., Mertins, P., Zhang, B., Hornbeck, P., Raju, R., Ahmad, R., Szucs, M., Mundt, F., Forestier, D., Jane-Valbuena, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000943 · Cited by 338
Self-citationProteomic maps of breast cancer subtypes
Tyanova, S., Albrechtsen, R., Kronqvist, P., Cox, J., Mann, M., & Geiger, T. (2016) · Nature Communications · doi:10.1038/ncomms10259 · Cited by 328
CDK4/6 inhibition in breast cancer: current practice and future directions
Pernas, S., Tolaney, S. M., Winer, E. P., & Goel, S. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918786451 · Cited by 316
Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1113-y · Cited by 297
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Chen, X., Li, J., Gray, W. H., Lehmann, B. D., Bauer, J. A., Shyr, Y., & Pietenpol, J. A. (2012) · Cancer Informatics · doi:10.4137/cin.s9983 · Cited by 292
Self-citationContEst: estimating cross-contamination of human samples in next-generation sequencing data
Cibulskis, K., McKenna, A., Fennell, T., Banks, E., DePristo, M., & Getz, G. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr446 · Cited by 289
Self-citationi-Tracker: For quantitative proteomics using iTRAQ™
Shadforth, I. P., Dunkley, T. P., Lilley, K. S., & Bessant, C. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-145 · Cited by 281
Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence
Tan, V. Y. F., & Fevotte, C. (2013) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2012.240 · Cited by 271
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Asghar, U. S., Barr, A. R., Cutts, R., Beaney, M., Babina, I., Sampath, D., Giltnane, J., Lacap, J. A., Crocker, L., Young, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0369 · Cited by 268
Kasar, S., Kim, J., Improgo, R., Tiao, G., Polak, P., Haradhvala, N., Lawrence, M. S., Kiezun, A., Fernandes, S. M., Bahl, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9866 · Cited by 260
Self-citationHBO1 Histone Acetylase Activity Is Essential for DNA Replication Licensing and Inhibited by Geminin
Miotto, B., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.012 · Cited by 258
Breast cancer quantitative proteome and proteogenomic landscape
Johansson, H. J., Socciarelli, F., Vacanti, N. M., Haugen, M. H., Zhu, Y., Siavelis, I., Fernandez-Woodbridge, A., Aure, M. R., Sennblad, B., Vesterlund, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09018-y · Cited by 235
Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
Chen, Y., Fu, L. L., Wen, X., Wang, X. Y., Liu, J., Cheng, Y., & Huang, J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.14 · Cited by 228
Clinical potential of mass spectrometry-based proteogenomics
Zhang, B., Whiteaker, J. R., Hoofnagle, A. N., Baird, G. S., Rodland, K. D., & Paulovich, A. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0135-7 · Cited by 210
Self-citationMishima, Y., Miyagi, S., Saraya, A., Negishi, M., Endoh, M., Endo, T. A., Toyoda, T., Shinga, J., Katsumoto, T., Chiba, T., et al. (2011) · Blood · doi:10.1182/blood-2011-01-331892 · Cited by 198
Dong, H., Adams, N. M., Xu, Y., Cao, J., Allan, D. S. J., Carlyle, J. R., Chen, X., Sun, J. C., & Glimcher, L. H. (2019) · Nature Immunology · doi:10.1038/s41590-019-0388-z · Cited by 172
Self-citationEstrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
Caldon, C. E. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00106 · Cited by 167
Condorelli, R., Mosele, F., Verret, B., Bachelot, T., Bedard, P. L., Cortés, J., Hyman, D., Juric, D., Krop, I. E., Bièche, I., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz036 · Cited by 164
Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions
Weinert, B. T., Moustafa, T., Iešmantavičius, V., Zechner, R., & Choudhary, C. (2015) · The EMBO Journal · doi:10.15252/embj.201591271 · Cited by 158
Methods, Tools and Current Perspectives in Proteogenomics
Ruggles, K. V., Krug, K., Wang, X., Clauser, K. R., Wang, J., Payne, S., Fenyö, D., Zhang, B., & Mani, D. R. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.mr117.000024 · Cited by 158
Self-citationSalomonis, N., Dexheimer, P. J., Omberg, L., Schroll, R., Bush, S., Huo, J. S., Schriml, L. M., Sui, S. H., Keddache, M. A., Mayhew, C. N., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.006 · Cited by 144
Self-citationMolecular Basis of Low-Penetrance Retinoblastoma
Harbour, J. W. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.11.1699 · Cited by 123
Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056226 · Cited by 119
Self-citationWeygant, N., Qu, D., Berry, W. L., May, R. J., Chandrakesan, P., Owen, D. B., Sureban, S. M., Ali, N., Janknecht, R., & Houchen, C. W. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-103 · Cited by 116
Rapid and deep-scale ubiquitylation profiling for biology and translational research
Udeshi, N. D., Mani, D. R., Satpathy, S., Fereshetian, S., Gasser, J. A., Svinkina, T., Olive, M. E., Ebert, B. L., Mertins, P., & Carr, S. A. (2020) · Nature Communications · doi:10.1038/s41467-019-14175-1 · Cited by 115
Self-citationMicroscaled proteogenomic methods for precision oncology
Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C. L., Singh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14381-2 · Cited by 113
Self-citationSmid, M., Rodríguez-González, F. G., Sieuwerts, A. M., Salgado, R., der Smissen, W. J. C. P., van der Vlugt‐Daane, M., van Galen, A., Nik‐Zainal, S., Staaf, J., Brinkman, A. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12910 · Cited by 106
Domains A and B in the Rb Pocket Interact To Form a Transcriptional Repressor Motif
Chow, K. N. B., & Dean, D. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4862 · Cited by 101
Interpreting pathways to discover cancer driver genes with Moonlight
Colaprico, A., Olsen, C., Bailey, M. H., Odom, G., Terkelsen, T., Silva, T. C., Olsen, A. V., Cantini, L., Zinovyev, A. Y., Barillot, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13803-0 · Cited by 101
Self-citationAutophosphorylation: a salient feature of protein kinases
Smith, J. A., Francis, S. H., & Corbin, J. D. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf01076757 · Cited by 98
DeTiN: overcoming tumor-in-normal contamination
Taylor-Weiner, A. N., Stewart, C., Giordano, T. J., Miller, M. L., Rosenberg, M. W., Macbeth, A., Lennon, N. J., Rheinbay, E., Landau, D. A., Wu, C. J., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0036-9 · Cited by 98
Self-citationONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES
Sokolov, A., Paull, E., & Stuart, J. M. (2015) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814749411_0037 · Cited by 95
Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry
Bouchal, P., Schubert, O. T., Faktor, J., Capkova, L., Imrichova, H., Zoufalova, K., Paralova, V., Hrstka, R., Liu, Y., Ebhardt, H. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.046 · Cited by 94
Weinstabl, H., Treu, M., Rinnenthal, J., Zahn, S. K., Ettmayer, P., Bader, G., Dahmann, G., Kessler, D., Rumpel, K., Mischerikow, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00718 · Cited by 87
Anurag, M., Punturi, N. B., Hoog, J., Bainbridge, M. N., Ellis, M. J., & Haricharan, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3702 · Cited by 85
Self-citationDaily, K., Ho Sui, S. J., Schriml, L. M., Dexheimer, P. J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.30 · Cited by 81
The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
Murphy, J. P., Giacomantonio, M., Paulo, J. A., Everley, R. A., Kennedy, B. E., Pathak, G. P., Clements, D. R., Kim, Y., Dai, C., Sharif, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.086 · Cited by 79
Haricharan, S., Punturi, N. B., Singh, P., Holloway, K. R., Anurag, M., Schmelz, J. L., Schmidt, C., Lei, J. T., Suman, V. J., Hunt, K. K., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1179 · Cited by 78
Self-citationImmune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)
Anurag, M., Zhu, M. M. T., Huang, C. L., Vasaikar, S. V., Wang, J., Hoog, J., Burugu, S., Gao, D., Suman, V. J., Zhang, X. H.-F., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz213 · Cited by 77
Self-citationAlhazzazi, T. Y., Kamarajan, P., Xu, Y., Ai, T., Chen, L., Verdin, E. M., & Kapila, Y. L. (2016) · PubMed · Cited by 74
Barker, L. E. (2002) · The American Statistician · doi:10.1198/000313002317572736 · Cited by 71
Mullarky, E., Xu, J., Robin, A. D., Huggins, D. J., Jennings, A. J., Noguchi, N., Olland, A. M., Damodharan, L., Miller, M. J., Tomita, D., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.011 · Cited by 71
Liu, C., Lau, K.-Y., Hsu, C., Chen, J.-L., Lee, C.-H., Huang, T., Chen, Y., Huang, C.-T., Lin, P., & Tseng, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189007 · Cited by 68
Self-citationYamamoto, T., Kanaya, N., Somlo, G., & Chen, S. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05104-9 · Cited by 62
Lin, C., Mabe, N. W., Lin, Y.-T., Yang, W., Tang, X., Hong, L. T., Sun, T., Force, J. M., Marks, J. R., Yao, T., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0499-y · Cited by 61
Sirtuin 3: A Janus face in cancer (Review)
Xiong, Y., Wang, M., Zhao, J., Han, Y., & Jia, L. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3767 · Cited by 53
Retinoblastoma protein expression and its predictors in triple-negative breast cancer
Patel, J. M., Goss, A. J., Garber, J. E., Torous, V. F., Richardson, E. T., Haviland, M. J., Hacker, M. R., Freeman, G. J., Nalven, T., Alexander, B. M., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0160-4 · Cited by 52
Novel Biomarkers for Personalized Cancer Immunotherapy
Shindo, Y., Hazama, S., Tsunedomi, R., Suzuki, N., & Nagano, H. (2019) · Cancers · doi:10.3390/cancers11091223 · Cited by 51
DNA damage repair defects as a new class of endocrine treatment resistance driver
Anurag, M., Ellis, M. J., & Haricharan, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26363 · Cited by 49
Self-citationVarn, F. S., Andrews, E. H., Mullins, D. W., & Cheng, C. (2016) · Nature Communications · doi:10.1038/ncomms10248 · Cited by 46
Autophosphorylation kinetics of protein kinases
Wang, Z., & Wu, J. (2002) · Biochemical Journal · doi:10.1042/bj20020557 · Cited by 38
High-Throughput Assessment of Kinome-Wide Activation States
Schmidlin, T., Debets, D. O., van Gelder, C. A. G. H., Stecker, K. E., Rontogianni, S., van den Eshof, B. L., Kemper, K., Lips, E. H., van den Biggelaar, M., Peeper, D. S., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2019.08.005 · Cited by 37
Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway
Chiang, J., & Martínez-Agosto, J. A. (2012) · Cells · doi:10.3390/cells1040886 · Cited by 19
Kawamura, D., Takemoto, Y., Nishimoto, A., Ueno, K., Hosoyama, T., Shirasawa, B., Tanaka, T., Kugimiya, N., Harada, E., & Hamano, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5974 · Cited by 19
Unveiling Hidden Dynamics of Hippo Signalling: A Systems Analysis
Shin, S., & Nguyen, L. K. (2016) · Genes · doi:10.3390/genes7080044 · Cited by 17
BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis
Blumenberg, L. M., Kawaler, E. A., Cornwell, M., Smith, S. A., Ruggles, K. V., & Fenyö, D. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00190 · Cited by 15
Self-citationThe emergence of TNIK as a therapeutic target for colorectal cancer
Masuda, M., & Yamada, T. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1297799 · Cited by 13
Interpreting pathways to discover cancer driver genes with Moonlight
Colaprico, A., Olsen, C., Bailey, M. H., Odom, G., Terkelsen, T., Silva, T. C., Olsen, A. V., Cantini, L., Zinovyev, A. Y., Barillot, E., et al. (2020) · doi:10.7490/f1000research.1118074.1 · Cited by 9
Self-citationHunt, A. L., Bateman, N. W., Barakat, W., Makohon‐Moore, S. C., Hood, B. L., Conrads, K. A., Zhou, M., Calvert, V. S., Pierobon, M., Loffredo, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/761155 · Cited by 6
Cited by
Triple negative breast cancer: Pitfalls and progress
Zagami, P., & Carey, L. A. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00468-0 · Cited by 839
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578
Self-citationZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Self-citationA proteogenomic portrait of lung squamous cell carcinoma
Satpathy, S., Krug, K., Jean Beltran, P. M., Savage, S. R., Petralia, F., Kumar-Sinha, C., Dou, Y., Reva, B., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 377
Self-citationIntegrative multi-omics approaches in cancer research: from biological networks to clinical subtypes
Heo, Y. J., Hwa, C., Lee, G.-H., Park, J.-M., & An, J.-Y. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0042 · Cited by 294
Metadata
- Authors
- Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L., Karpova, A., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., Heiman, D. I., Cao, S., Maruvka, Y. E., Lei, J. T., Huang, C., Kothadia, R. B., Colaprico, A., Birger, C., Wang, J., Dou, Y., Wen, B., Shi, Z., Liao, Y., Wiznerowicz, M., Wyczalkowski, M. A., Chen, X. S., Kennedy, J. J., Paulovich, A. G., Thiagarajan, M., Kinsinger, C. R., Hiltke, T., Boja, E. S., Mesri, M., Robles, A. I., Rodriguez, H., Westbrook, T. F., Ding, L., Getz, G., Clauser, K. R., Fenyö, D., Ruggles, K. V., Zhang, B., Mani, D. R., Carr, S. A., Ellis, M. J., Gillette, M. A., Avanessian, S. C., Cai, S., Chan, D., Chen, X., Edwards, N. J., Hoofnagle, A. N., Kane, M. H., Ketchum, K. A., Kuhn, E., Levine, D. A., Li, S., Liebler, D. C., Liu, T., Luo, J., Madhavan, S., Maher, C., McDermott, J. E., McGarvey, P. B., Oberti, M., Pandey, A., Payne, S. H., Ransohoff, D. F., Rivers, R. C., Rodland, K. D., Rudnick, P., Sanders, M. E., Shaw, K. M., Shih, I.-M., Slebos, R. J. C., Smith, R. D., Snyder, M., Stein, S. E., Tabb, D. L., Thangudu, R. R., Thomas, S., Wang, Y., White, F. M., Whiteaker, J. R., Whiteley, G. A., Zhang, H., Zhang, Z., Zhao, Y., Zhu, H., & Zimmerman, L. J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 183
- Issue
- 5
- Pages
- 1436-1456.e31
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3104755560
- Cited by
- 537
- References
- 150
- FWCI
- 23.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.